Objective: To describe the phenotype of levodopa-induced "on" freezing of gait (FOG) in Parkinson disease (PD).
Methods:We present a diagnostic approach to separate "on" FOG (deterioration during the "on state") from other FOG forms. Four patients with PD with suspected "on" FOG were examined in the "off state" (Ͼ12 hours after last medication intake), "on state" (peak effect of usual medication), and "supra-on" state (after intake of at least twice the usual dose).Results: Patients showed clear "on" FOG, which worsened in a dose-dependent fashion from the "on" to the "supra-on" state. Two patients also demonstrated FOG during the "off state," of lesser magnitude than during "on." In addition, levodopa produced motor blocks in hand and feet movements, while other parkinsonian features improved. None of the patients had cognitive impairment or a predating "off " FOG.
Conclusions:True "on" FOG exists as a rare phenotype in PD, unassociated with cognitive impairment or a predating "off " FOG. Distinguishing the different FOG subtypes requires a comprehensive motor assessment in at least 3 medication states. Neurology
Freezing of gait (FOG) is common in Parkinson disease (PD). FOG refers to sudden, relatively brief episodes of gait arrest, experienced subjectively by patients as their feet being "glued to the floor."1 The relationship between FOG and dopaminergic medication is complex. Most common is "off " FOG, which is relieved by dopaminergic medication.1 Less well recognized types include "unresponsive FOG," which is indifferent to changes in dopaminergic medication 2,3 ; "pseudo-on" FOG, seen during a seemingly optimal "on" state, but which nevertheless improves with stronger dopaminergic stimulation; and "on" FOG, induced by dopaminergic medication. 4 Here, we describe the phenotype of "on" FOG, illustrated by 4 patients with PD. We also present a diagnostic approach to separate the various FOG subtypes, as a basis for understanding pathophysiology and for tailored therapeutic intervention.METHODS Four patients (ages 59 -82, disease duration 6 -20 years) with a history of deteriorating FOG during "on" are described in appendix e-1 on the Neurology ® Web site at www.neurology.org. Subjects were tested in 3 states: 1) "practically defined off " state, after 12 hours without medication; 2) "on" state, 45-60 minutes after intake of regular levodopa doses; and 3) "supra-on" state, after at least twice the regular dose. The Institutional Review Board approved the study protocol and written informed consent was obtained. These tests were done on 1 day, in a fixed order, without blinding. Subject 3 was also tested 1 month later in the "supra-off " state, after 72 hours without any medication. Motor evaluations included the Unified Parkinson's Disease Rating Scale (UPDRS)-III subscale (table e-1) and timed gait tasks (gait initiation, straight walking with 2 180-degree turns, and 1 360-degree turn in each direction). Determination of FOG appearance was based on patient and investigator judgment.Standard proto...